O-linked α2,3 sialylation defines stem cell populations in breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
O-linked α2,3 sialylation defines stem cell populations in breast cancer
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 1, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-01-08
DOI
10.1126/sciadv.abj9513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell RNA-seq dissects the intratumoral heterogeneity of triple negative breast cancer based on gene regulatory networks
- (2021) Shunheng Zhou et al. Molecular Therapy-Nucleic Acids
- High FUT3 expression is a marker of lower overall survival of breast cancer patients
- (2020) Jessica Catarine Frutuoso do Nascimento et al. GLYCOCONJUGATE JOURNAL
- O-GlcNAc Transferase Regulates Cancer Stem–like Potential of Breast Cancer Cells
- (2020) Neha M. Akella et al. MOLECULAR CANCER RESEARCH
- Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition
- (2020) Heena Jariyal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- CD44 splice isoform switching determines breast cancer stem cell state
- (2019) Honghong Zhang et al. GENES & DEVELOPMENT
- O‐glycan truncation enhances cancer‐related functions of CD 44 in gastric cancer
- (2019) Stefan Mereiter et al. FEBS LETTERS
- The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
- (2019) Dannielle D. Engle et al. SCIENCE
- Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
- (2019) Indrė Januškevičienė et al. LIFE SCIENCES
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- VEGF–neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin
- (2018) Ameer L. Elaimy et al. Science Signaling
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility
- (2018) Sujeethraj Koppolu et al. ACS Infectious Diseases
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
- (2016) Matthew J. Schultz et al. CANCER RESEARCH
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Protein Glycosylation in Cancer
- (2015) Sean R. Stowell et al. Annual Review of Pathology-Mechanisms of Disease
- MMR: a tool for read multi-mapper resolution
- (2015) André Kahles et al. BIOINFORMATICS
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer
- (2015) Jason B. Ross et al. NATURE CELL BIOLOGY
- A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells
- (2015) Binwu Tang et al. Stem Cell Reports
- Terminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains
- (2014) Christina E. Faller et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
- (2013) Jennifer M. Curry et al. JOURNAL OF SURGICAL ONCOLOGY
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
- (2013) Daehwan Kim et al. GENOME BIOLOGY
- Distinct Kinetic and Molecular Requirements Govern CD44 Binding to Hyaluronan versus Fibrin(ogen)
- (2012) Phrabha S. Raman et al. BIOPHYSICAL JOURNAL
- Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands
- (2012) W. H. Yang et al. BLOOD
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells
- (2011) J. S. Merzaban et al. BLOOD
- Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers
- (2011) S. Julien et al. CANCER RESEARCH
- The biology of CD44 and HCELL in hematopoiesis: the ‘step 2-bypass pathway’ and other emerging perspectives
- (2011) Robert Sackstein CURRENT OPINION IN HEMATOLOGY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1
- (2008) K. Engelmann et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started